SNOA (MC $23 M) (Cash $13 M) Lots of Marketed Products Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNOA (MC $23 M) (Cash $13 M) Lots of Marketed Products

SNOA 4.038

+4.3%

Oct 29 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: BioHero	10/25/2017 9:36:05 AM
	of 11

new presentation ir.sonomapharma.com Sales Plan to Achieve Profitability •6-9 month sales ramp to breakeven for sales force investment Added 13 field sales reps and 1 sales manager •Total of 30 field sales reps and 5 senior sales managers •Add/ subdivide new territories Launch 3 New Products –one every six months •Loyon and Ceramax extensions Grow current product portfolio with all sales people •Alevicyn, SebuDerm, Ceramax, Celacyn & Mondoxyne Grow with Price Increases •Expect to increase dermatology product prices by 10% to 20% in 2017 Revenue and cash from new partnerships

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next